ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction. - Wikidata - awgldk - TriplyDB

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

http://www.wikidata.org/entity/Q34648653

about

Zofenopril and incidence of cough: a review of published and unpublished data.Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use Medication management of chronic heart failure in older adults.A History of Asthma From Childhood and Left Ventricular Mass in Asymptomatic Young Adults: The Bogalusa Heart Study.Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care.Effects of enalapril and imidapril in the capsaicin cough challenge test and spirometry parameters in healthy volunteers

P2860

Q34097737-8EDBC045-E418-4BFF-B4CB-929B4B3792F7 Q37678020-E9E9F0B1-FD17-4A85-BD27-878C223969BB Q38126374-0BE9DA96-E19F-4B68-8795-F550F921801E Q39498099-3A754144-1351-46A3-979C-AAA0B83A43D5 Q49832113-9FC88553-6EC7-4414-8F72-9DC72F74F1FB Q49832147-B4A2277D-1FDD-4EFC-8BF7-A122D146161B Q59284852-6144C9DD-B3DD-4247-9AD4-4705057EC70D

P2860

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

http://www.wikidata.org/entity/Q34648653

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@ast

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@en

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@nl

type

label

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@ast

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@en

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@nl

prefLabel

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@ast

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@en

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@nl

P1433

Q34648653-75880542-1EB8-40ED-AA5C-112A0CEA08B5

P1476

Q34648653-AA7FBA57-C648-4619-82F2-409E52B1C6B6

P2093

Q34648653-46E3535B-66F0-4B1B-B453-3AE1B43419F2

Q34648653-A2F8EEC0-DE4E-4417-B70A-87E349AF37E1

Q34648653-B7FF85AB-7E65-4129-BB97-2F38BEF6B69C

P2860

Q34648653-081EA524-5BEF-4D72-BDFA-57DCF2A798D2

Q34648653-1A6AAC86-376F-40EE-9B72-C9AB819D4789

Q34648653-1D2E349D-B055-4E45-A84E-899E69224EF0

Q34648653-24A7BBA1-4BF3-4F7B-AABC-BA2C1716E9C9

Q34648653-35DAABFD-6A3A-449A-81C1-1369790B97F7

Q34648653-3DA0B054-94D4-4FBB-88C4-43924868E45C

Q34648653-469A5225-3E94-4B6C-B14C-8E7B769884CB

Q34648653-50F58F67-D59F-4EF8-BA7A-BE91C14D9E6E

Q34648653-660024B3-FAE6-4F1B-926B-89E57E4D2B71

Q34648653-661E3961-D330-4F12-B9A7-722108D36F23

P304

Q34648653-D58E653A-C33D-4177-BA76-26643DD74896

P31

Q34648653-4E43B5BA-A30C-4323-A42B-8AC7FEC166F2

Q34648653-cb236911-0d87-4bfb-adb3-662dd6b8375f

P356

Q34648653-29B4A8A5-B5AA-450A-AA83-5D049032D395

P407

Q34648653-67D029E4-96D7-4030-A2DC-D6014B317519

P433

Q34648653-D343EB80-749A-47B7-8DE0-15D149F76428

P478

Q34648653-5DB5AF53-BC1C-43BC-994A-95DFFBB06CF8

P577

Q34648653-EFBF68D7-9EF4-48C2-8D15-565FCFF82501

P698

Q34648653-7DA3A718-4558-4546-854C-DA8465CFDDD2

P356

P1433

Annals of Pharmacotherapy

P1476

ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction.

@en

P2093

Amy J Arouni

http://www.w3.org/2001/XMLSchema#string

Kathleen A Packard

http://www.w3.org/2001/XMLSchema#string

Richard L Wurdeman

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme.

Adverse effects profile of sulfhydryl compounds in man

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.

THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE.

The effect of bradykinin on proximal tubular sodium reabsorption in the dog: evidence for functional nephron heterogeneity

Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

P304

1058-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1A332

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12022909

http://www.w3.org/2001/XMLSchema#string